Top Story

FDA acknowledges receipt of Shire’s resubmitted NDA for lifitegrast

February 5, 2016

The FDA has acknowledged receipt of a new drug application resubmitted by Shire for lifitegrast to treat signs and symptoms of dry eye disease, the company announced in a press release.

Shire resubmitted the application in response to a complete response letter in which the FDA requested an additional clinical study and more information on product quality, the release said.

FDA News

Oculus receives 510(k) clearance for Pentacam AXL

February 5, 2016
The Pentacam AXL has received 510(k) clearance from the FDA, Oculus announced in a press release.The device, which combines anterior segment tomography and optical…
Meeting News CoverageVideo

VIDEO: Neuro-ophthalmologist encourages colleagues to check pupil as sign of serious disease

February 5, 2016
WAIKOLOA, Hawaii — At Hawaiian Eye, Andrew G. Lee, MD, discusses neuro-ophthalmology as an "ophthalmic superpower," which enables ophthalmologists to home in on life-…
Meeting News CoverageVideo

VIDEO: Surgeon discusses advantages of standard operating protocol for managing dry eye disease

February 4, 2016
WAIKOLOA, Hawaii — At Hawaiian Eye, Elizabeth Yeu, MD, discusses how implementing a standard protocol for assessing new cases of dry eye disease has made patient…
Business News

Visionary Venture Fund and Advisory Board to support ophthalmology startups

February 4, 2016
OCTANe, a business development accelerator, has launched the Visionary Venture Fund and Advisory Board to assist later-stage ophthalmology startup companies, according…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »

Using Treatment as Prevention: New and Emerging Options for Miosis, Postoperative Pain, and Inflammation

This activity is supported by an educational grant from Omeros Corporation.

Patients expect optimal vision immediately after cataract surgery, especially patients who have had premium IOLs…
More »
Meeting News CoverageVideo

VIDEO: FDA working with glaucoma community, patients in MIGS development

February 2, 2016
More »